News on U.S. government agencies, U.S. politics, companies doing business with U.S. federal government. Read U.S. national and local news. This site is not affiliated with United States Government.
(USGovernment-News.Com, September 21, 2017 ) There is never a dull moment in the pharmaceutical industry as it is always marked by a flurry of high-profile activity such as partnerships and licensing agreements, M&A, and investments. Market Research Hub has recently added a new report on the ‘Partnerships, Licensing, Investments and M&A Deals and Trends for June 2017 in Pharmaceuticals’ in its repository. This report offers a detailed look at the licensing and partnership transactions, private equity, venture financing, and equity and debt offerings in the pharmaceutical industry in June 2017. Data has been provided for a historical period going all the way back to August 2016 to give an idea of the volatility one can expect in the pharmaceutical industry. The information has been logically laid out in the form of therapy area, milestone and upfront payments and payment mode. In addition to this, the report has critical data pertaining to the top financial advisory firms that are actively involved in the pharmaceutical industry. Key advisors that play an outsized role in deals and trends in the pharmaceutical industry such as Goldman Sachs, Credit Suisse, and Morgan Stanley have been separately highlighted in the report.
Detailed Analysis of M&A Activity Across Diverse Pharmaceutical Segments The report has comprehensively covered all the recent activity in segments as wide-ranging as dermatology, cardiovascular disorders, gastrointestinal disorders, dental and mouth disorders, respiratory ailments, women’s health, toxicology, ophthalmology, hematological disorders, metabolic disorders, musculoskeletal disorders, and male health among many others. There is an examination of therapy areas that are extremely prominent in terms of partnerships, licensing agreements, M&As and venture capital financing. The analysis further includes an evaluation of different payment modes such as milestone and upfront payments, especially in licensing agreements and partnerships in the industry.
Equal Focus on Emerging and Developed Economies The MRH report covers the entire globe with an adequate emphasis on both developed as well as emerging economies. The regions studied are North America, Europe, APAC, and the rest of the world. The summary of all the deals agreed upon, their value in terms of US$ million and the total number have all been mentioned. The ‘deal of the month’ for each region has been specially stated in the report.
What is the report USP? The report goes a long way in enhancing a stakeholder’s decision-making ability in a time sensitive yet efficient manner. It is invaluable in understanding the best-performing segments that are particularly lucrative investment opportunities. The report reader is able to evaluate various companies that are entering into licensing or partnership agreements and even acquiring or divesting their asset holdings. The report allows the identification of venture capitalists that finance biotech and pharmaceutical organizations and also companies that seek to raise capital in the most aggressive fashion. The report enables readers to get a firm grasp on how close competitors finance their endeavors and how M&A activity has shaped the pharmaceutical industry as a whole. Lastly, the report can help assess growth segments in each region within the pharmaceutical industry and assist the search for financial advisors that can aid in M&A and capital raising decisions.
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Industry resource center today to browse our selection of 600+ complimentary Industry magazines, white papers, webinars, podcasts, and more. Get popular titles including:
